Bank of Nova Scotia’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Bank of Nova Scotia's VRTX Position: Q2 2026 in Review
Bank of Nova Scotia reduced its Vertex Pharmaceuticals (VRTX) stake by 22% in Q2 2026, selling an estimated $3.44M and leaving 27,607 shares worth $13.7M. The position accounts for 0.02% of the portfolio, ranked #425.
Bank of Nova Scotia first reported a position in VRTX in Q3 2013 and has held it in 52 quarters since. The position peaked at $121M in Q2 2020. 1,296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Bank of Nova Scotia held 27,607 shares of Vertex Pharmaceuticals worth $13.7M as of Q2 2026.
- Bank of Nova Scotia sold 7,754 Vertex Pharmaceuticals shares in Q2 2026, an estimated $3.44M.
- Vertex Pharmaceuticals made up 0.02% of Bank of Nova Scotia's portfolio in Q2 2026, its #425 holding.
- Bank of Nova Scotia first reported a position in Vertex Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
- Bank of Nova Scotia's Vertex Pharmaceuticals position peaked at $121M in Q2 2020.
- 1,296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.